ENG/中
老虎证券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登录
立即注册
Toggle
美股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
ASTRAZENECA PLC ADRhedged
53.28
0.0000
成交量:
- -
成交额:
- -
市值:
159.83万
市盈率:
- -
高:
53.28
开:
53.28
低:
53.28
收:
53.28
52周最高:
56.90
52周最低:
49.87
股本:
3.00万
流通股本:
1.00万
量比:
2.68
换手率:
- -
股息:
0.58
股息率:
1.08%
净资产收益率:
--
总资产收益率:
--
市净率:
--
市盈率(LYR):
- -
数据加载中...
总览
公司
新闻资讯
公告
阿斯利康将在ASCO 2026公布多项III期数据,涵盖肝癌、乳腺癌、膀胱癌及罕见病疗法
环球市场播报
·
05/22
欧洲药品管理局对阿斯利康乳腺癌新药给予积极指导意见
环球市场播报
·
05/22
广药接手达安基因;阿斯利康高血压创新药获美国FDA批准
21世纪经济报道
·
05/19
阿斯利康高血压药物获美国批准
环球市场播报
·
05/18
阿斯利康(AZN)旗下创新降压药Baxfendy获批 加码高血压治疗领域
金吾财讯
·
05/18
流行病诊疗板块多股扬升 雅培(ABT)涨1.60%、强生(JNJ)涨1.12%
金吾财讯
·
05/12
世界狼疮日|“主场时刻”患者关爱行动在沪启幕,助百万"蝶友"迈向临床缓解新篇章
美通社
·
05/10
多家药企高管生变:恒瑞、复星、阿斯利康、辉瑞…
赛柏蓝
·
05/07
伯恩斯坦将阿斯利康目标价从20500便士下调至18600便士。
智通财经
·
05/01
美国监管委员会投票否决乳腺癌药物后,阿斯利康股价下跌
路透中文
·
05/01
阿斯利康乳腺癌候选药物未获FDA咨询委员会投票通过
环球市场播报
·
05/01
FDA顾问委员会推荐阿斯利康Truqap用于PTEN缺陷型转移性激素敏感性前列腺癌
美股速递
·
05/01
阿斯利康行使选择权 根据协议条款向Pintree Therapeutics支付2500万美元交割款项
美股速递
·
04/30
阿斯利康宣布3亿英镑对英投资,涵盖去年暂停的剑桥研发基地后续建设
美股速递
·
04/29
阿斯利康CEO:英国药价政策方向正确,欧美将展开类似讨论
美股速递
·
04/29
阿斯利康CEO:英美医药协议将惠及患者,提升药物可及性
美股速递
·
04/29
《美股》阿斯利康(AZN.US)首季核心每股盈利胜预期 维持全年盈收预测
阿斯达克财经
·
04/29
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hans/stock/AZNH/news?page=9"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AZNH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AZNH\",,,,,undefined,":{"symbol":"AZNH","market":"US","secType":"STK","nameCN":"ASTRAZENECA PLC ADRhedged","latestPrice":53.2774,"timestamp":1791835200000,"preClose":53.2774,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":10000,"shares":30000,"eps":0,"marketStatus":"停牌","change":0,"latestTime":"10-13 07:29:56 EDT","open":53.2774,"high":53.2774,"low":53.2774,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791898200000},"marketStatusCode":1,"adr":0,"exchange":"NYSE","adjPreClose":53.2774,"dividendRate":0.010836,"bidAskSpread":0,"volumeRatio":2.6812474453400963},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AZNH\",,,,,undefined,":{"symbol":"AZNH","floatShares":10000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":2.6812474453400963,"shares":30000,"dividePrice":0.57729,"high":53.2774,"amplitude":0,"preClose":53.2774,"low":53.2774,"week52Low":49.87,"pbRate":"--","week52High":56.8955,"institutionHeld":0,"latestPrice":53.2774,"eps":0,"divideRate":0.010836,"volume":0,"delay":0,"ttmEps":0,"open":53.2774,"prevYearClose":54.226,"prevWeekClose":53.2774,"prevMonthClose":53.2774,"prevQuarterClose":53.2774,"fiveDayClose":53.2774,"twentyDayClose":53.2774,"sixtyDayClose":53.2774},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AZNH\",params:#limit:5,,,undefined,":[{"date":"2025-12-16","symbol":"AZNH","amount":0.57729,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"ASTRAZENECA PLC ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-24"},{"date":"2024-12-16","symbol":"AZNH","amount":2.71402,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-16","defaultRemindTime":1734359400000,"name":"ASTRAZENECA PLC ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-23","payableDate":"2024-12-16","currency":"USD","dateTimestamp":1734325200000,"payDate":"2024-12-23"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AZNH\",market:\"US\",,,undefined,":[{"executeDate":"2024-12-16","recordDate":"2024-12-16","paymentDate":"2024-12-23","value":2.71402,"currency":"USD"},{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-24","value":0.57729,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AZNH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AZNH\",pageSize:20,pageCount:9,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2637334314","title":"阿斯利康将在ASCO 2026公布多项III期数据,涵盖肝癌、乳腺癌、膀胱癌及罕见病疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=2637334314","media":"环球市场播报","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637334314?lang=zh_cn&edition=fundamental","pubTime":"2026-05-22 23:33","pubTimestamp":1779463980,"startTime":"0","endTime":"0","summary":"阿斯利康于5月22日宣布,将在5月29日至6月2日举行的2026年美国临床肿瘤学会年会上,公布超过85篇摘要,涵盖10款已获批药物和13款潜在新药,其中包括25项口头报告。 在肝癌方面,将公布EMERALD-3 III期试验结果。 在膀胱癌方面,将公布POTOMAC III期试验的5年总生存期分析,该试验评估了Imfinzi联合卡介苗治疗高危非肌层浸润性膀胱癌的疗效。 在罕见病方面,将展示anselamimab的III期临床项目数据。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-05-22/doc-inhyuwee5028220.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU2236285917.USD","LU0889565916.HKD","LU2417539215.USD","LU0289739699.SGD","AZN","BK4588","LU0109394709.USD","BK4568","AZNH","LU2237443549.SGD","BK4585","III","LU2456880835.USD","LU1829250122.USD","LU2237443978.SGD","IE00B3T34201.USD","LU2237443465.HKD","LU2462157665.USD","BK4134","LU2237443622.USD","LU2237443895.HKD","LU0058720904.USD","BK4007","LU0320765992.SGD","LU2237443382.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637889316","title":"欧洲药品管理局对阿斯利康乳腺癌新药给予积极指导意见","url":"https://stock-news.laohu8.com/highlight/detail?id=2637889316","media":"环球市场播报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637889316?lang=zh_cn&edition=fundamental","pubTime":"2026-05-22 18:57","pubTimestamp":1779447420,"startTime":"0","endTime":"0","summary":"欧洲药品管理局下属委员会22日发布评估结论,对阿斯利康公司研发的实验性乳腺癌药物camizestrant正式出具积极意见。 该决定与美国监管部门此前的初步立场形成对比。数周前,美国食品药品监督管理局顾问委员会曾投票否决该疗法的相关申请。 加速新药获批是阿斯利康扩大全球市场份额的核心战略。据阿斯利康预测,camizestrant仍有望于今年内获得美国监管机构批准,其年销售额峰值预计将突破50亿美元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-05-22/doc-inhyumqk5199163.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["AZN","BK4588","AZNH","LU2237443622.USD","LU0109394709.USD","BK4585","LU1829250122.USD","LU2417539215.USD","LU2237443978.SGD","LU0320765992.SGD","LU2237443895.HKD","BK4568","LU2237443465.HKD","LU0889565916.HKD","LU2456880835.USD","BK4007","LU2237443382.USD","LU0289739699.SGD","LU2462157665.USD","IE00B3T34201.USD","LU0058720904.USD","LU2236285917.USD","LU2237443549.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636700080","title":"广药接手达安基因;阿斯利康高血压创新药获美国FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2636700080","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636700080?lang=zh_cn&edition=fundamental","pubTime":"2026-05-19 08:01","pubTimestamp":1779148914,"startTime":"0","endTime":"0","summary":"政策动向2026年医保目录调整新增预申报允许商保创新药申报医保目录国家医保局介绍2026年国家医保药品目录及商业健康保险创新药品目录调整工作安排,包括首次允许纳入2025年商保创新药目录的药品申报国家医保目录,新增“预申报”环节等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605193741160824.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605193741160824.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0122","LU2237443382.USD","BK0028","BK1574","BK4585","002030","BK4588","LABU","BK0042","BK4007","AZNH","LU0320765992.SGD","LU2237443549.SGD","BK0168","LU0058720904.USD","BK4568","BK0046","LU0889565916.HKD","159992","BK1161","LU2236285917.USD","LU2237443895.HKD","LU1829250122.USD","06978","BK0239","LU2237443465.HKD","LU2417539215.USD","AZN","LU0289739699.SGD","LU2456880835.USD","IE00B3T34201.USD","LU2237443978.SGD","BK0188","BK0159","LU2237443622.USD","LU0109394709.USD","LU2462157665.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636252030","title":"阿斯利康高血压药物获美国批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2636252030","media":"环球市场播报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636252030?lang=zh_cn&edition=fundamental","pubTime":"2026-05-18 16:46","pubTimestamp":1779093960,"startTime":"0","endTime":"0","summary":"阿斯利康表示,其一款新型高血压疗法已获得美国批准。这家英国制药公司由此获准将该药推向市场,并预计其年销售额在峰值时将达到数十亿美元。此次获批扩充了阿斯利康的心血管、肾脏和代谢产品组合。Farxiga不仅是阿斯利康在该治疗领域的最大单品,也是该公司史上最畅销的药物。 阿斯利康表示,Baxfendy采用了一种全新的高血压治疗方式。 2023年,阿斯利康通过收购CinCor Pharma获得了对Baxfendy的控制权。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-05-18/doc-inhyiewm2878231.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU2237443549.SGD","BK4007","LU2237443895.HKD","LU0058720904.USD","LU1829250122.USD","LU2237443465.HKD","AZN","LU2462157665.USD","LU0320765992.SGD","IE00B3T34201.USD","LU2236285917.USD","LU2237443622.USD","LU0109394709.USD","LU0889565916.HKD","LU2417539215.USD","AZNH","BK4585","LU2237443978.SGD","LU2456880835.USD","LU0289739699.SGD","BK4588","LU2237443382.USD","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636023010","title":"阿斯利康(AZN)旗下创新降压药Baxfendy获批 加码高血压治疗领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2636023010","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636023010?lang=zh_cn&edition=fundamental","pubTime":"2026-05-18 16:21","pubTimestamp":1779092477,"startTime":"0","endTime":"0","summary":"从安全性来看,Baxfendy 总体耐受性良好,临床试验期间未发现任何意外安全问题,用药安全性得到充分验证。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250107/NjEzNTY0MzU5MDE2.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/NjEzNTY0MzU5MDE2.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"300527","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","AZN","LU2237443382.USD","LU0320765992.SGD","BK4568","IE00B3T34201.USD","AZNH","BK4585","LU0058720904.USD","LU0289739699.SGD","BK4588","LU2456880835.USD","LU0109394709.USD","LU2237443895.HKD","BK4007","LU2237443549.SGD","LU2237443978.SGD","LU2417539215.USD","LU2236285917.USD","LU2237443622.USD","LU2462157665.USD","LU1829250122.USD","LU2237443465.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634101862","title":"流行病诊疗板块多股扬升 雅培(ABT)涨1.60%、强生(JNJ)涨1.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2634101862","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634101862?lang=zh_cn&edition=fundamental","pubTime":"2026-05-12 22:05","pubTimestamp":1778594751,"startTime":"0","endTime":"0","summary":"金吾财讯 | 汉坦病毒疫情叠加药企药物研发/合作进展向好消息提振,美股流行病诊疗板块多股扬升,截至发稿,葛兰素史克 涨 1.93%,雅培 涨 1.60%,默沙东 涨 1.41%,阿斯利康 涨 1.18%,强生 涨 1.12%。达歌生物周二宣布与默沙东研发(中国)有限公司签署合作协议,共同推进抗肿瘤药物临床合作开发。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250107/MzZmY2I0ODMyNDljNDZhYjk1YmMwYzA2ZTYzZmI3NWMyMTczNjIzMDYxMjY4Mg==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/MzZmY2I0ODMyNDljNDZhYjk1YmMwYzA2ZTYzZmI3NWMyMTczNjIzMDYxMjY4Mg==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"300341","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B42XCP33.USD","LU1989763690.USD","LU2237443622.USD","SG9999001176.USD","LU2089984988.USD","LU0859254822.USD","LU1989763427.SGD","LU2129689605.HKD","LU2491049909.HKD","SG9999014542.SGD","LU2602419157.SGD","LU1037948541.HKD","LU0124676726.USD","IE00B19Z3581.USD","LU0792757196.USD","LU1032955483.USD","IE00B4R5TH58.HKD","LU0545562505.USD","LU1196500208.SGD","LU1674673428.USD","IE00B7SZLL34.SGD","LU1699723380.USD","LU2468319806.SGD","BK4534","LU1244550577.SGD","IE000BZT7R73.USD","LU0058720904.USD","LU1291159041.SGD","LU0210528500.USD","LU1721429402.USD","LU1721429741.USD","LU1894683264.USD","LU2023250504.SGD","LU2505996681.GBP","LU1571399168.USD","LU1066053197.SGD","IE0034235303.USD","LU1043141396.HKD","BK4581","LU2023250330.USD","IE00BDGV0183.EUR","LU1228905540.USD","LU1934455194.USD","LU1037948897.HKD","LU1228905037.USD","LU2133065610.SGD","SG9999014559.SGD","LU0345769631.USD","LU0266013472.USD","LU0345769128.USD","LU0820561909.HKD","IE00BFXG1179.USD","LU2430703095.HKD","LU0070217475.USD","LU1914381329.SGD","LU1983299246.USD","LU0211331839.USD","LU0965508806.USD","BK4568","LU2125154778.USD","LU0689472784.USD","LU1267930813.SGD","LU2471134879.HKD","LU1066051498.USD","LU2750360641.GBP","LU0345770308.USD","LU2491050071.SGD","IE000WAW04H5.SGD","BK4504","LU1732800096.USD","LU0320765646.SGD","LU0683600562.USD","JNJ","BK4082","AZN","LU0477156953.USD","LU0965509283.SGD","LU1201861249.SGD","LU1941712264.USD","SGXZ41872573.SGD","SGXZ57979304.SGD","IE0000B7K699.USD","LU0114720955.EUR","LU1059921491.USD","SG9999002224.SGD","BK4592","LU2361045086.USD","LU0795875086.SGD","LU2756315664.SGD","LU0882574055.USD","LU0426412945.USD","LU0320765992.SGD","LU0985320562.USD","LU1691799644.USD","LU2237443382.USD","LU2462157665.USD","LU0861579265.USD","LU0053666078.USD","LU1585245621.USD","LU2106854487.HKD","LU0994945656.USD","BK4588","LU0943347566.SGD","LU1551013425.SGD","IE0002141913.USD","LU0265550946.USD","LU0942090050.USD","LU1061106388.HKD","LU2361044865.SGD","LU0320765489.SGD","BK4516","LU2237443549.SGD","BK4550","LU1496350502.SGD","LU2112291526.USD","IE0009355771.USD","BK4585","LU0640476718.USD","LU0820562030.AUD","LU2237443895.HKD","LU2471134523.USD","LU1778281490.HKD","LU1244550221.USD","LU1069347547.HKD","LU0170899867.USD","IE00B3PB1722.GBP","LU2491050154.USD","IE00B3T34201.USD","IE00BKVL7J92.USD","IE00B1BXHZ80.USD","LU2347655156.SGD","LU0964807845.USD","SG9999001176.SGD","SG9999014575.USD","IE00BLSP4239.USD","LU0868494617.USD","LU1093756325.SGD","BK4007","IE00BJT1NW94.SGD","LU0234570918.USD","LU1506573853.SGD","LU1093756168.USD","LU0208291251.USD","IE00BLSP4452.SGD","LU2417539215.USD","LU1917777945.USD","LU1261432733.SGD","LU0098860793.USD","LU1043141123.HKD","LU1074936037.SGD","LU2505996509.AUD","LU0122379950.USD","SG9999013999.USD","LU1974910355.USD","GSK.UK","BK4559","LU1829250122.USD","SG9999015341.SGD","LU2471134796.USD","LU2592432038.USD","LU1551013342.USD","LU1732799900.SGD","LU2896262040.SGD","LU2324357040.USD","LU2461242641.AUD","SG9999015358.SGD","LU1023059063.AUD","LU1121112475.USD","LU0795875169.SGD","SG9999002232.USD","LU1221951046.USD","LU1244550494.USD","LU1145028129.USD","IE00BN8TJ469.HKD","LU2237443465.HKD","IE000SO60NU8.SGD","LU0980610538.SGD","LU2023250843.SGD","IE00BFTCPJ56.SGD","LU2357627491.SGD","IE00BJJMRZ35.SGD","LU2430703178.SGD","LU1066051811.HKD","LU0130102774.USD","LU0265550359.USD","LU0432979614.USD","LU0109394709.USD","LU2360032135.SGD","IE00BBT3K403.USD","LU2236285917.USD","GSKH","LU0345770993.USD","LU0965509010.AUD","LU1066051225.USD","LU2125154935.USD","IE00BGHQF631.EUR","IE00BVYPNW00.USD","LU0234572021.USD","LU1934455277.USD","IE00BZ1G4Q59.USD","LU0130517989.USD","LU1941712348.USD","LU2129689431.USD","LU2237443978.SGD","LU2361044949.HKD","MRK","ABT","IE000M9KFDE8.USD","LU1280957306.USD","BK4532","LU0912757837.SGD","LU1032466523.USD","LU2756315318.SGD","LU1116320737.USD","LU1989772840.SGD","IE00B19Z3B42.SGD","LU1221951129.SGD","LU2487616109.SGD","IE000MB6IJN5.SGD","LU1934455863.HKD","LU0203347892.USD","LU2129689514.USD","LU2211815571.USD","LU2750360997.AUD","IE00B2B36J28.USD","LU0868494708.USD","LU0466842654.USD","LU2430703251.USD","LU0203345920.USD","LU2403377893.USD","LU2237957811.SGD","GSK","LU0648001328.SGD","LU1989772923.USD","SG9999004303.SGD","LU1894683348.USD","LU1162221912.USD","LU0289739699.SGD","LU2471134952.CNY","LU1674673691.USD","LU1935042991.SGD","LU0238689110.USD","BK4566","IE0002270589.USD","LU0106261372.USD","LU1057294990.SGD","LU0889566641.SGD","AZNH","LU0820561818.USD","IE000F7OJYX1.SGD","LU1430594728.SGD","LU1629891620.HKD","LU0006306889.USD","IE0001KFT4U8.USD","LU0889565916.HKD","IE00BSNM7G36.USD","SG9999014567.USD","BK4533","IE00BVYPNV92.GBP","LU0210536198.USD","LU2237957902.USD","LU2456880835.USD","LU1929549753.HKD","LU0965509101.SGD","LU1989771016.USD","LU0426417589.USD","SGXZ23171101.USD","SG9999001440.SGD","LU0689626769.HKD","LU0787776722.HKD","LU2213496289.HKD","LU1035773651.USD","LU0070302665.USD","LU1718418525.SGD","LU1116320901.HKD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2634544008","title":"世界狼疮日|“主场时刻”患者关爱行动在沪启幕,助百万\"蝶友\"迈向临床缓解新篇章","url":"https://stock-news.laohu8.com/highlight/detail?id=2634544008","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634544008?lang=zh_cn&edition=fundamental","pubTime":"2026-05-10 20:09","pubTimestamp":1778414940,"startTime":"0","endTime":"0","summary":"在2026年5月10日世界狼疮日,由新华网和患者组织SLE解忧杂货铺联合主办、阿斯利康中国支持的“主场时刻”系统性红斑狼疮患者关爱行动在上海正式启幕。全球范围内系统性红斑狼疮患者人数超过340万。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"prnasia","url":"http://wwwold.prnasia.com/story/archive/4955695_ZH55695_1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://wwwold.prnasia.com/story/archive/4955695_ZH55695_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["SLE","LU2237443549.SGD","AZN","BK4585","BK4588","BK4007","LU2237443895.HKD","LU0889565916.HKD","IE00B3T34201.USD","LU2237443382.USD","ACR","LU0109394709.USD","LU2417539215.USD","LU2237443978.SGD","BK4077","LU2237443622.USD","AZNH","BK4568","LU2237443465.HKD","BK4110","LU2456880835.USD","LU0289739699.SGD","LU0320765992.SGD","LU1829250122.USD","LU2462157665.USD","LU0058720904.USD","LU2236285917.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633794147","title":"多家药企高管生变:恒瑞、复星、阿斯利康、辉瑞…","url":"https://stock-news.laohu8.com/highlight/detail?id=2633794147","media":"赛柏蓝","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633794147?lang=zh_cn&edition=fundamental","pubTime":"2026-05-07 19:53","pubTimestamp":1778154780,"startTime":"0","endTime":"0","summary":"01本土制药企业与Biotech迎高管变动恒瑞医药、再鼎医药、百济神州、和铂医药、复星医药映射出了中国创新药发展过程中企业所处的不同阶段。4月16日,恒瑞医药发布公告,正式完成新一届董事会和管理层聘任。复星医药4月2日,复星医药发布首席财务官变更公告,因工作安排调整,陈战宇辞去首席财务官职务。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-05-07/doc-inhxatff4708181.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IE000M9KFDE8.USD","LU0234572021.USD","IE00B19Z3B42.SGD","IE00BBT3K403.USD","LU2237443549.SGD","SG9999002224.SGD","SG9999002232.USD","BK4550","SG9999013999.USD","LU1057294990.SGD","SG9999011175.SGD","SGXZ57979304.SGD","688235","LU0321505439.SGD","LU2417539215.USD","LU1883839398.USD","LU1066053197.SGD","LU0985481810.HKD","BK4592","BK4599","BK4007","IE0002270589.USD","600196","LU0868494617.USD","BK4568","BK4533","BK4585","600276","LU2237443382.USD","02196","LU2462157665.USD","LU0320765992.SGD","LU0306806265.USD","LU1894683264.USD","ONC","LU0289739699.SGD","IE00BLSP4452.SGD","LU0889565916.HKD","01276","IE00BLSP4239.USD","LU0321505868.SGD","LU0306807586.USD","LU0122379950.USD","LU1829250122.USD","SG9999001176.USD","IE00B3T34201.USD","LU1023059063.AUD","LU2456880835.USD","LU1894683348.USD","BK4534","02142","LU0225771236.USD","LU0225284248.USD","LU0456855351.SGD","LU0058720904.USD","LU2236285917.USD","06160","BK4588","LU1066051498.USD","LU2237443622.USD","SG9999001176.SGD","LU2237443895.HKD","BK4581","LU2237443465.HKD","PFE","LU0170899867.USD","SG9999003800.SGD","AZNH","AZN","IE00B19Z3581.USD","LU2237443978.SGD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632619163","title":"伯恩斯坦将阿斯利康目标价从20500便士下调至18600便士。","url":"https://stock-news.laohu8.com/highlight/detail?id=2632619163","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632619163?lang=zh_cn&edition=fundamental","pubTime":"2026-05-01 19:09","pubTimestamp":1777633776,"startTime":"0","endTime":"0","summary":"","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["AZNH","AZN","AZN.UK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632618147","title":"美国监管委员会投票否决乳腺癌药物后,阿斯利康股价下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2632618147","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632618147?lang=zh_cn&edition=fundamental","pubTime":"2026-05-01 16:31","pubTimestamp":1777624295,"startTime":"0","endTime":"0","summary":"更新 2-美国监管委员会投票否决乳腺癌药物后,阿斯利康股价下跌专家小组以试验设计存在问题为由,投票反对卡米泽特兰分析师称卡米泽特兰仍有获批可能ODAC支持阿斯利康的Truqap用于治疗转移性前列腺癌股价下跌1.9%在第3段补充Truqap的投票结果,第6和8段补充分析师评论,第7和9段补充阿斯利康的业绩目标及股价详情","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260501:nL4S41E0B6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZNH","LU1989772923.USD","LU1989772840.SGD","LU1046234339.USD","LU1061106388.HKD","AZN","IE0034235188.USD","LU0122379950.USD","LU1084165304.USD","LU1153584641.USD","LU1496350171.SGD","LU0499090636.EUR","LU2133065610.SGD","LU0859254822.USD","LU1019634622.SGD","LU1267930490.SGD","LU1267930227.SGD","LU1051770623.HKD","LU2468319806.SGD","LU1023059063.AUD","LU0047473722.SGD","LU0640478417.SGD","LU0211327993.USD","LU2089984988.USD","LU0289739699.SGD","LU2023251221.USD","LU0823416689.USD","LU0203347892.USD","LU0128525689.USD","LU2324357040.USD","IE0009355771.USD","SG9999001176.SGD","LU0882574055.USD","LU2357627491.SGD","LU1003077747.HKD","LU0203345920.USD","LU0432979614.USD","LU2125909593.SGD","IE00B2B36J28.USD","LU0553294199.USD","LU1104425308.USD","LU1019632923.USD","LU2433249047.HKD","SG9999001176.USD","AZN.UK","LU2112291526.USD","LU0058720904.USD","LU1481600234.SGD","LU1196032939.SGD","LU2355687059.USD","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632504618","title":"阿斯利康乳腺癌候选药物未获FDA咨询委员会投票通过","url":"https://stock-news.laohu8.com/highlight/detail?id=2632504618","media":"环球市场播报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632504618?lang=zh_cn&edition=fundamental","pubTime":"2026-05-01 16:14","pubTimestamp":1777623240,"startTime":"0","endTime":"0","summary":"在乳腺癌候选药物未能在一项关键的咨询委员会投票中获得支持后,英国制药集团阿斯利康表示,该公司将继续与美国监管机构合作,对该药物进行审查。该公司周四晚间表示,美国食品药品管理局的肿瘤药物咨询委员会以6比3的投票结果,对乳腺癌治疗候选药物camizestrant的获益-风险评估给出否定性意见。阿斯利康的股价在周五开盘交易中下跌了约1.8%。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-05-01/doc-inhwktza5459710.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU2237443895.HKD","LU0889565916.HKD","BK4588","LU2462157665.USD","BK4568","AZN.UK","LU2237443549.SGD","LU2237443978.SGD","LU2237443382.USD","LU2237443465.HKD","AZNH","LU1829250122.USD","LU2237443622.USD","LU2236285917.USD","BK4007","LU0058720904.USD","LU2456880835.USD","LU0320765992.SGD","AZN","IE00B3T34201.USD","LU0289739699.SGD","BK4585","LU0109394709.USD","LU2417539215.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161357099","title":"FDA顾问委员会推荐阿斯利康Truqap用于PTEN缺陷型转移性激素敏感性前列腺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=1161357099","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161357099?lang=zh_cn&edition=fundamental","pubTime":"2026-05-01 05:49","pubTimestamp":1777585759,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局顾问委员会近日对阿斯利康制药旗下抗癌药物Truqap给予积极推荐,支持其用于治疗PTEN缺陷型转移性激素敏感性前列腺癌患者。该研究证实,在PTEN缺失的转移性激素敏感性前列腺癌患者中,Truqap治疗方案能显著延长影像学无进展生存期,为这类特定人群提供了新的精准治疗选择。FDA通常遵循顾问委员会的建议,但最终决定仍待官方审评。若获批,Truqap将成为首个针对PTEN缺陷型mHSPC的靶向疗法,填补当前治疗格局中的重要空白。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0887340254.USD","LU2089984988.USD","LU1119994496.HKD","AZNH","LU2089284900.SGD","LU0029864427.USD","LU2112291526.USD","LU0310800965.SGD","LU0784385170.HKD","LU0976567544.SGD","LU1273509221.SGD","LU0011850046.USD","LU0211327993.USD","LU1019632923.USD","LU0390134368.USD","LU0859254822.USD","LU0972486137.USD","LU0211326839.USD","LU0957799991.USD","LU1487256676.USD","LU1291159041.SGD","LU1323610961.USD","LU2023251221.USD","LU0310799852.SGD","LU1496350171.SGD","LU0432979614.USD","LU0949170772.SGD","LU0963555726.SGD","LU2293690249.USD","LU1481599808.USD","LU1084165304.USD","LU1496350502.SGD","LU0077335932.USD","LU0496365809.HKD","LU0920783379.SGD","SG9999013999.USD","LU1989772923.USD","LU1261432733.SGD","LU2293690082.USD","LU0171293334.USD","LU0708994859.HKD","LU0047473722.EUR","LU1196032939.SGD","LU1814569148.SGD","IE0009355771.USD","LU0823416689.USD","AZN","LU2324357040.USD","LU0345777659.USD","LU0784383803.USD","LU2089283258.USD","LU0557290698.USD","LU0823399737.USD","LU0203345920.USD","LU1880407132.USD","SGXZ57979304.SGD","LU0920840948.USD","LU2279689827.SGD","LU2539964713.USD","LU0827474353.SGD","LU1267930227.SGD","IE00B4R5TH58.HKD","LU1003077747.HKD","LU2091194634.USD","LU1046234339.USD","BK5011","LU1989772840.SGD","LU0211328371.USD","LU0738911758.USD","LU0128525689.USD","LU0784385840.USD","LU0997586432.USD","LU0784384876.USD","LU1267930490.SGD","LU0211326755.USD","IE00BJJMRZ35.SGD","LU0889566641.SGD","LU0792757196.USD","LU1989771016.USD","LU1019634622.SGD","LU0310800379.SGD","LU0640478417.SGD","IE00BJT1NW94.SGD","LU0499090636.EUR","LU0158827948.USD","LU0545039389.USD","LU2355687059.USD","LU0203347892.USD","LU1153585028.USD","LU2133065610.SGD","LU0289739699.SGD","IE00BKPKM643.USD","LU0047473722.SGD","LU0949170426.SGD","LU0969580561.USD","SG9999001176.USD","IE00B3T34201.USD","LU1003076772.USD","AZN.UK","LU1061106388.HKD","SG9999001176.SGD","LU0122379950.USD","LU2125909247.SGD","LU1015430645.USD","LU1064927863.SGD","LU1104425308.USD","LU0553294199.USD","LU1301847155.USD","LU1153584641.USD","LU2125909593.SGD","LU0997586515.USD","LU1051770623.HKD","LU0128525929.USD","LU1267930813.SGD","LU0526926950.USD","LU0960981461.USD","LU2357627491.SGD","LU2108987350.USD","LU2468319806.SGD","IE0034235188.USD","LU1267930573.SGD","LU0757432116.USD","LU0889565080.SGD","LU1983299246.USD","LU0266013472.USD","LU0857590862.USD","LU1057294990.SGD","IE00BFTCPJ56.SGD","LU0661504455.SGD","LU0575583348.USD","LU0345777147.USD","LU0964806797.USD","IE0002141913.USD","LU0882574055.USD","LU1481600234.SGD","LU1923622614.USD","LU0058720904.USD","LU1078025761.USD","LU0052756011.USD","LU0114720955.EUR","LU1023059063.AUD","LU2114397693.USD","LU1170363599.USD","IE00B2B36J28.USD","LU2433249047.HKD","LU1880407215.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171095508","title":"阿斯利康行使选择权 根据协议条款向Pintree Therapeutics支付2500万美元交割款项","url":"https://stock-news.laohu8.com/highlight/detail?id=1171095508","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171095508?lang=zh_cn&edition=fundamental","pubTime":"2026-04-30 07:03","pubTimestamp":1777503805,"startTime":"0","endTime":"0","summary":"根据双方达成的协议条款,阿斯利康制药行使选择权,此举触发了其向Pintree Therapeutics支付一笔高达2500万美元的选择权交割款项。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0784385840.USD","LU0738911758.USD","LU0963555726.SGD","SG9999013999.USD","LU1084165304.USD","LU2293690082.USD","IE00BFTCPJ56.SGD","IE0002141913.USD","LU0345777147.USD","LU1003076772.USD","LU1078025761.USD","LU2125909593.SGD","LU0029864427.USD","LU0960981461.USD","SG9999001176.SGD","LU1989772840.SGD","IE00BKPKM643.USD","LU0640478417.SGD","LU0889566641.SGD","IE0034235188.USD","LU0757432116.USD","LU0708994859.HKD","LU1487256676.USD","LU0964806797.USD","LU0158827948.USD","IE00B3T34201.USD","LU1153585028.USD","LU1267930227.SGD","LU1196032939.SGD","LU1496350171.SGD","LU0499090636.EUR","LU0557290698.USD","IE00BJT1NW94.SGD","LU2112291526.USD","LU0390134368.USD","LU1989772923.USD","LU2468319806.SGD","LU0882574055.USD","LU1023059063.AUD","LU1061106388.HKD","LU2433249047.HKD","LU2089284900.SGD","LU0128525689.USD","LU0345777659.USD","LU0976567544.SGD","LU0310800965.SGD","LU0310799852.SGD","LU1481600234.SGD","LU0997586515.USD","LU2023251221.USD","LU0077335932.USD","LU0857590862.USD","LU0661504455.SGD","LU0784384876.USD","LU0211327993.USD","AZN.UK","LU0047473722.SGD","IE00B2B36J28.USD","LU0310800379.SGD","LU1273509221.SGD","LU0553294199.USD","LU1814569148.SGD","BK5011","LU0920783379.SGD","LU1261432733.SGD","LU1323610961.USD","LU0949170426.SGD","LU2108987350.USD","LU1267930573.SGD","LU0823399737.USD","LU1481599808.USD","LU1267930813.SGD","LU0114720955.EUR","LU0887340254.USD","LU2355687059.USD","LU1301847155.USD","LU2324357040.USD","LU1989771016.USD","LU2293690249.USD","LU1267930490.SGD","LU0823416689.USD","LU0949170772.SGD","LU0526926950.USD","LU1064927863.SGD","LU0052756011.USD","IE00BJJMRZ35.SGD","LU1019632923.USD","AZN","LU1019634622.SGD","LU2089984988.USD","LU0011850046.USD","LU1170363599.USD","LU0784383803.USD","LU0432979614.USD","LU1003077747.HKD","LU2114397693.USD","LU0496365809.HKD","LU0266013472.USD","LU1880407215.USD","LU1104425308.USD","IE00B4R5TH58.HKD","LU1051770623.HKD","LU2539964713.USD","LU1015430645.USD","AZNH","LU1057294990.SGD","LU0972486137.USD","LU1880407132.USD","SGXZ57979304.SGD","LU0957799991.USD","LU0058720904.USD","LU1046234339.USD","LU0211326755.USD","LU0122379950.USD","LU2279689827.SGD","LU0575583348.USD","LU0211328371.USD","LU0047473722.EUR","LU0969580561.USD","LU0128525929.USD","LU0203347892.USD","LU0289739699.SGD","LU0997586432.USD","LU0171293334.USD","LU2125909247.SGD","LU2357627491.SGD","LU0203345920.USD","LU1153584641.USD","LU0827474353.SGD","LU2089283258.USD","SG9999001176.USD","LU2133065610.SGD","LU1983299246.USD","LU0920840948.USD","LU1496350502.SGD","LU1119994496.HKD","LU1291159041.SGD","LU1923622614.USD","LU0889565080.SGD","IE0009355771.USD","LU0784385170.HKD","LU0211326839.USD","LU2091194634.USD","LU0859254822.USD","LU0545039389.USD","LU0792757196.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159873248","title":"阿斯利康宣布3亿英镑对英投资,涵盖去年暂停的剑桥研发基地后续建设","url":"https://stock-news.laohu8.com/highlight/detail?id=1159873248","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159873248?lang=zh_cn&edition=fundamental","pubTime":"2026-04-29 19:51","pubTimestamp":1777463500,"startTime":"0","endTime":"0","summary":"阿斯利康制药首席执行官帕斯卡尔·索里奥特今日宣布,公司将对英国投资3亿英镑。此项投资计划包含完成去年一度暂停的剑桥研发基地建设项目。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0203345920.USD","LU2324357040.USD","LU0345777147.USD","LU2089283258.USD","LU1273509221.SGD","LU2125909593.SGD","LU2112291526.USD","LU2433249047.HKD","LU0969580561.USD","LU2539964713.USD","LU1084165304.USD","LU0310799852.SGD","LU0496365809.HKD","IE00BKPKM643.USD","LU1267930573.SGD","LU0827474353.SGD","LU0545039389.USD","LU0310800379.SGD","LU0963555726.SGD","LU0211327993.USD","LU0553294199.USD","LU0575583348.USD","LU1023059063.AUD","LU1064927863.SGD","LU0122379950.USD","LU0661504455.SGD","LU2108987350.USD","LU2125909247.SGD","LU1301847155.USD","LU2023251221.USD","LU0823399737.USD","LU0784383803.USD","LU0114720955.EUR","LU0029864427.USD","LU2357627491.SGD","LU0972486137.USD","LU0784385840.USD","LU1078025761.USD","LU1989772840.SGD","LU0499090636.EUR","LU0857590862.USD","LU0957799991.USD","LU2293690082.USD","LU1267930227.SGD","LU2089284900.SGD","LU0920840948.USD","LU0949170426.SGD","LU0784385170.HKD","LU1989771016.USD","LU0047473722.EUR","LU0390134368.USD","LU1267930813.SGD","LU2089984988.USD","LU1989772923.USD","LU1003076772.USD","IE0002141913.USD","LU1196032939.SGD","LU0792757196.USD","LU0203347892.USD","LU0077335932.USD","LU1496350502.SGD","LU1170363599.USD","LU1267930490.SGD","LU0859254822.USD","LU0757432116.USD","LU1015430645.USD","LU2133065610.SGD","LU1814569148.SGD","LU0889565080.SGD","LU0976567544.SGD","LU1481599808.USD","LU0964806797.USD","LU1057294990.SGD","LU0158827948.USD","IE00B4R5TH58.HKD","LU0557290698.USD","BK5011","LU0882574055.USD","LU1487256676.USD","LU1323610961.USD","LU1061106388.HKD","LU1153585028.USD","LU2355687059.USD","LU1019632923.USD","LU0997586515.USD","IE0009355771.USD","LU0960981461.USD","LU0432979614.USD","LU0211326755.USD","LU1983299246.USD","LU1496350171.SGD","LU0997586432.USD","LU1481600234.SGD","LU2091194634.USD","LU0345777659.USD","LU0889566641.SGD","SG9999013999.USD","LU1046234339.USD","LU0784384876.USD","LU0128525689.USD","LU0920783379.SGD","AZN.UK","LU0266013472.USD","LU1003077747.HKD","AZN","LU0211326839.USD","AZNH","LU1104425308.USD","LU0171293334.USD","LU0949170772.SGD","IE00B2B36J28.USD","LU1923622614.USD","LU0640478417.SGD","LU0526926950.USD","LU1880407132.USD","SG9999001176.SGD","LU1153584641.USD","LU0211328371.USD","LU0310800965.SGD","LU0047473722.SGD","LU0128525929.USD","LU0823416689.USD","IE0034235188.USD","IE00BJT1NW94.SGD","LU0708994859.HKD","LU0887340254.USD","LU1291159041.SGD","LU0052756011.USD","LU2279689827.SGD","LU0011850046.USD","LU1051770623.HKD","LU2468319806.SGD","IE00BFTCPJ56.SGD","LU1019634622.SGD","LU2114397693.USD","SG9999001176.USD","LU0289739699.SGD","LU1261432733.SGD","LU2293690249.USD","IE00B3T34201.USD","LU0738911758.USD","LU0058720904.USD","LU1119994496.HKD","LU1880407215.USD","IE00BJJMRZ35.SGD","SGXZ57979304.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109836577","title":"阿斯利康CEO:英国药价政策方向正确,欧美将展开类似讨论","url":"https://stock-news.laohu8.com/highlight/detail?id=1109836577","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109836577?lang=zh_cn&edition=fundamental","pubTime":"2026-04-29 19:50","pubTimestamp":1777463429,"startTime":"0","endTime":"0","summary":"阿斯利康制药首席执行官帕斯卡尔·索里奥表示,英国政府在药品定价政策上正朝着正确的方向迈进。他指出,未来欧洲与美国之间也将展开性质相似的讨论。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089284900.SGD","LU2279689827.SGD","LU0969580561.USD","LU1880407132.USD","LU0211328371.USD","LU1046234339.USD","LU1301847155.USD","LU0345777147.USD","LU0114720955.EUR","LU0784384876.USD","LU0310799852.SGD","IE0009355771.USD","AZN","LU0526926950.USD","LU0738911758.USD","LU0949170426.SGD","LU0784385170.HKD","IE00B3T34201.USD","LU2108987350.USD","LU0827474353.SGD","LU0997586515.USD","LU1078025761.USD","LU0859254822.USD","LU1989772923.USD","LU2133065610.SGD","LU1481599808.USD","LU1064927863.SGD","LU2355687059.USD","LU2112291526.USD","LU1261432733.SGD","LU0052756011.USD","LU0964806797.USD","LU0545039389.USD","LU1487256676.USD","LU1983299246.USD","LU0640478417.SGD","LU0266013472.USD","LU0553294199.USD","LU1153585028.USD","IE00BFTCPJ56.SGD","LU2539964713.USD","LU0920783379.SGD","LU0047473722.SGD","LU0345777659.USD","LU2023251221.USD","LU2114397693.USD","LU0889565080.SGD","LU2357627491.SGD","LU1051770623.HKD","LU0310800379.SGD","LU1923622614.USD","LU0857590862.USD","LU1104425308.USD","LU0122379950.USD","LU1170363599.USD","LU1119994496.HKD","LU1880407215.USD","IE0034235188.USD","LU0557290698.USD","LU1084165304.USD","LU0011850046.USD","LU0289739699.SGD","LU0887340254.USD","LU2125909247.SGD","LU1019634622.SGD","LU0792757196.USD","LU1019632923.USD","LU0310800965.SGD","LU1003076772.USD","LU1267930490.SGD","LU1023059063.AUD","LU0708994859.HKD","LU0211326839.USD","LU0158827948.USD","LU1267930227.SGD","LU1061106388.HKD","LU0882574055.USD","IE00BJT1NW94.SGD","LU2468319806.SGD","LU0029864427.USD","LU1496350171.SGD","LU1814569148.SGD","LU0889566641.SGD","LU0972486137.USD","LU0784385840.USD","LU0390134368.USD","LU0203347892.USD","LU1057294990.SGD","LU0757432116.USD","LU2089283258.USD","LU0957799991.USD","LU1267930573.SGD","LU2091194634.USD","LU0661504455.SGD","IE00B4R5TH58.HKD","LU0997586432.USD","AZNH","LU0496365809.HKD","LU0128525689.USD","IE0002141913.USD","LU0823399737.USD","LU1989771016.USD","SGXZ57979304.SGD","LU0575583348.USD","AZN.UK","LU1273509221.SGD","IE00BKPKM643.USD","IE00B2B36J28.USD","LU0976567544.SGD","LU0058720904.USD","LU2293690249.USD","LU0784383803.USD","BK5011","LU1291159041.SGD","LU0823416689.USD","LU1989772840.SGD","LU2324357040.USD","LU0128525929.USD","LU2125909593.SGD","LU2293690082.USD","LU0963555726.SGD","LU1496350502.SGD","LU0211326755.USD","LU1481600234.SGD","LU2433249047.HKD","LU0077335932.USD","LU0960981461.USD","LU1003077747.HKD","LU1323610961.USD","LU0949170772.SGD","LU0203345920.USD","LU1153584641.USD","SG9999001176.SGD","IE00BJJMRZ35.SGD","LU0171293334.USD","LU0920840948.USD","SG9999001176.USD","LU2089984988.USD","LU1267930813.SGD","SG9999013999.USD","LU1015430645.USD","LU0211327993.USD","LU0047473722.EUR","LU0432979614.USD","LU1196032939.SGD","LU0499090636.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125435733","title":"阿斯利康CEO:英美医药协议将惠及患者,提升药物可及性","url":"https://stock-news.laohu8.com/highlight/detail?id=1125435733","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125435733?lang=zh_cn&edition=fundamental","pubTime":"2026-04-29 19:35","pubTimestamp":1777462524,"startTime":"0","endTime":"0","summary":"阿斯利康制药首席执行官帕斯卡尔·索里奥表示,近期达成的美国与英国之间的医药合作协议,将有效改善患者的药物获取渠道。索里奥在媒体电话会议上指出,这一合作框架有望简化新药审批流程,并促进创新疗法更快速地惠及有需要的患者群体。他强调,加强国际协作对于应对全球健康挑战至关重要,而此项协议正是推动医药领域进步的重要一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0997586432.USD","LU1057294990.SGD","LU0784385840.USD","LU0784384876.USD","LU1880407215.USD","LU0557290698.USD","LU2125909593.SGD","LU0859254822.USD","LU1104425308.USD","LU2125909247.SGD","LU0114720955.EUR","LU1084165304.USD","LU1003077747.HKD","LU1496350171.SGD","IE00B2B36J28.USD","LU2468319806.SGD","LU0738911758.USD","LU0960981461.USD","LU0526926950.USD","LU0310800379.SGD","AZNH","LU0345777147.USD","LU0203345920.USD","LU0957799991.USD","LU1496350502.SGD","LU0171293334.USD","LU1078025761.USD","LU0310800965.SGD","LU1170363599.USD","LU0211328371.USD","LU1119994496.HKD","LU1061106388.HKD","LU2357627491.SGD","LU0266013472.USD","LU0882574055.USD","LU0964806797.USD","LU1989771016.USD","LU1880407132.USD","LU0047473722.EUR","LU2089284900.SGD","LU0128525689.USD","LU0757432116.USD","LU1291159041.SGD","LU2279689827.SGD","LU0575583348.USD","LU1267930813.SGD","LU0390134368.USD","LU2539964713.USD","LU0052756011.USD","LU0889565080.SGD","LU1267930573.SGD","SG9999001176.SGD","LU0203347892.USD","LU0827474353.SGD","LU2023251221.USD","LU0058720904.USD","LU1481599808.USD","LU2355687059.USD","LU0432979614.USD","LU1064927863.SGD","LU0949170426.SGD","LU0496365809.HKD","LU0310799852.SGD","LU0077335932.USD","LU1273509221.SGD","LU1989772840.SGD","LU1814569148.SGD","LU2293690249.USD","LU0969580561.USD","LU1153585028.USD","LU2133065610.SGD","LU0211326839.USD","LU0784385170.HKD","LU2114397693.USD","LU0972486137.USD","LU2091194634.USD","LU2089283258.USD","SGXZ57979304.SGD","LU0011850046.USD","LU1261432733.SGD","LU1267930490.SGD","LU1481600234.SGD","AZN","LU1487256676.USD","LU0553294199.USD","LU2089984988.USD","AZN.UK","LU1301847155.USD","LU1019634622.SGD","LU0661504455.SGD","BK5011","LU1051770623.HKD","LU1023059063.AUD","LU1983299246.USD","SG9999001176.USD","IE00B3T34201.USD","LU2112291526.USD","LU1267930227.SGD","LU0128525929.USD","LU0949170772.SGD","LU0211327993.USD","SG9999013999.USD","LU0545039389.USD","LU0047473722.SGD","LU0976567544.SGD","LU0857590862.USD","LU1323610961.USD","IE0002141913.USD","LU0823416689.USD","IE00BJJMRZ35.SGD","LU0920783379.SGD","LU1196032939.SGD","IE00BKPKM643.USD","LU0211326755.USD","LU2293690082.USD","LU0920840948.USD","IE0034235188.USD","LU0887340254.USD","LU0997586515.USD","LU0158827948.USD","LU0963555726.SGD","LU0708994859.HKD","IE00BJT1NW94.SGD","LU0784383803.USD","LU1046234339.USD","LU1923622614.USD","LU0640478417.SGD","LU2433249047.HKD","LU0122379950.USD","LU1019632923.USD","LU0823399737.USD","LU0889566641.SGD","LU1015430645.USD","LU2324357040.USD","LU0289739699.SGD","IE0009355771.USD","LU0499090636.EUR","LU2108987350.USD","LU1153584641.USD","LU0345777659.USD","IE00B4R5TH58.HKD","LU0029864427.USD","LU0792757196.USD","LU1003076772.USD","LU1989772923.USD","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631614155","title":"《美股》阿斯利康(AZN.US)首季核心每股盈利胜预期 维持全年盈收预测","url":"https://stock-news.laohu8.com/highlight/detail?id=2631614155","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631614155?lang=zh_cn&edition=fundamental","pubTime":"2026-04-29 14:49","pubTimestamp":1777445340,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20211209122201027_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20211209122201027_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1521388/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1521388/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["AZN","AZNH","AZN.UK"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":9,"totalSize":177,"code":"91000000","status":"200"}]}}